Lipocine Inc. | Ownership
Companies that own Lipocine Inc.
J. Goldman & Co. LP
715,000
3.36%
715,000
0.09%
06/30/2018
The Vanguard Group, Inc.
708,084
3.33%
-1,661
0%
06/30/2018
BlackRock Fund Advisors
299,870
1.41%
-35,940
0%
06/30/2018
Ameriprise Financial Services, Inc. (Investment Management)
161,500
0.76%
100
0%
06/30/2018
Dimensional Fund Advisors LP
148,192
0.7%
-4,394
0%
06/30/2018
Renaissance Technologies LLC
105,900
0.5%
24,000
0%
06/30/2018
Geode Capital Management LLC
104,428
0.49%
0
0%
06/30/2018
Morgan Stanley & Co. LLC
88,570
0.42%
-165
0%
06/30/2018
Group One Trading LP
67,452
0.32%
3,620
0.01%
06/30/2018
Jacobs Levy Equity Management, Inc.
64,910
0.31%
64,910
0%
06/30/2018
| Address |
675 Arapeen Drive
Salt Lake City Utah 84108
United States
|
|
Employees
|
- |
| Website |
http://www.lipocine.com |
| Updated |
07/08/2019 |
| Lipocine, Inc. is a pharmaceutical company, which engages in the research and development of treatment for use in men's and women's health through proprietary drug delivery technologies. It focuses on the oral testosterone replacement therapy and preterm birth prevention. The company was founded on July 24, 2013 and is headquartered in Salt Lake City, UT. |
